Natural history of hepatocellular adenoma formation in glycogen storage disease type I.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Jornal de Pediatria

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jpeds.2011.02.031PMID 21481415PMCID PMC3135733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism and proliferation share common regulatory pathways in cancer cells

  2010cited by this paper
• Subtype Classification of Hepatocellular Adenoma

  2010cited by this paper
• Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.

  2009cited by this paper
• Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience

  2009cited by this paper
• Hyperlipidemia in glycogen storage disease type III: Effect of age and metabolic control

  2008cited by this paper
• Mutations in the glucose‐6‐phosphatase‐α (G6PC) gene that cause type Ia glycogen storage disease

  2008cited by this paper
• Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.

  2008cited by this paper
• Disturbed lipid metabolism in glycogen storage disease type 1

  2007cited by this paper
• Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC

  2006cited by this paper
• Fatty acid synthase and cancer: new application of an old pathway.

  2006cited by this paper
• Overexpression of fatty acid synthase in chemically and hormonally induced hepatocarcinogenesis of the rat

  2005cited by this paper
• Glycogen storage disease I and hepatocellular tumours

  2005cited by this paper
• Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I)

  2002cited by this paper
• Disturbed lipid metabolism in glycogen storage disease type 1

  2002cited by this paper
• Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport.

  2002cited by this paper
• Glycogen storage disease type I: pathophysiology of liver adenomas

  2002cited by this paper
• Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease

  2002cited by this paper
• Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature.

  1997cited by this paper
• Cornstarch therapy in type I glycogen-storage disease.

  1984cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Glycogen disease of the liver (von Gierke's disease) with hepatomata; case report with metabolic studies.

  1955cited by this paper

• Efficacy of magnetic resonance imaging in managing glycogen storage disease

  2025cites this paper
• Liquid-liquid phase separation: A dynamic driver of hepatocellular carcinoma.

  2025cites this paper
• Clinical characteristics of 50 hepatocellular adenoma patients among 164 cases of glycogen storage disease type Ia

  2025cites this paper
• MRI features of hepatocellular adenomas in children: clinical and radiological review

  2025cites this paper
• Empagliflozin as treatment in glycogen storage disease type IB patients

  2025cites this paper
• Short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study

  2024cites this paper
• Diagnosing glycogen storage disease type 1b in adulthood: A case with multiple hepatocellular adenomas

  2024cites this paper
• Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study

  2024cites this paper
• Paediatric hepatocellular adenomas: Lessons from a systematic review of relevant literature

  2024cites this paper
• Hepatic Adenoma: Evolution of a More Individualized Treatment Approach.

  2024cites this paper
• Integrative analysis of pathogenic variants in glucose-6-phosphatase based on an AlphaFold2 model

  2024cites this paper
• Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy

  2023cites this paper
• Glycogen storage diseases: An update

  2023cites this paper
• Amnio acid substitution at position 298 of human glucose-6 phosphatase-α significantly impacts its stability in mammalian cells

  2023cites this paper
• Gene therapy for glycogen storage diseases

  2023cites this paper
• Treatment outcomes on growth of children diagnosed with glycogen storage disease presenting to national institute of child health, Karachi, Pakistan.

  2023cites this paper
• Molecular mechanisms of catalytic inhibition for active site mutations in glucose-6-phosphatase catalytic subunit 1 linked to glycogen storage disease

  2023cites this paper
• High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia

  2022influential citation
• Novel monitoring and management strategies for hepatic glycogen storage diseases

  2022cites this paper
• Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects?

  2022cites this paper
• Understanding hepatic Glycogen Storage Disease type Ia: role of phenotypic heterogeneity and nutrient sensors

  2022cites this paper
• Successful Treatment of Refractory Anemia in a Patient With Glycogen Storage Disease Type Ia Undergoing Hemodialysis

  2022cites this paper
• Glycogen storage disease type 1a in the Ohio Amish

  2022cites this paper
• Beyond predicting diagnosis: Is there a role for measuring biotinidase activity in liver glycogen storage diseases?

  2022cites this paper
• Pediatric Primary Hepatic Tumors: Diagnostic Considerations

  2021cites this paper
• Disorders of Carbohydrate Metabolism

  2021cites this paper
• Diagnostic challenges and risk stratification of hepatocellular adenoma

  2021cites this paper
• Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs

  2021cites this paper
• Liver transplantation for benign liver tumors

  2021cites this paper
• Clinical, Biochemical and Molecular Characterization of a Cohort of Glycogen Storage Disease Type I Patients in a High Complexity Hospital in Argentina

  2021cites this paper
• Intraoperative Evaluation of the Liver, Extrahepatic Bile Ducts, Gallbladder, and Pancreas

  2021cites this paper
• Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR‐associated protein 9–Mediated Gene Editing

  2021cites this paper
• Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia

  2021cites this paper
• mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease

  2021cites this paper
• Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia

  2021cites this paper
• "Bull’s eye” appearance of hepatocellular adenomas in patients with glycogen storage disease type I — atypical magnetic resonance imaging findings: Two case reports

  2021cites this paper
• Hepatocellular Neoplasms Arising in Genetic Metabolic Disorders: Steatosis is Common in Both Tumor and Background Liver.

  2020cites this paper
• Hepatic Glycogenoses Among Children-Clinical and Biochemical Characterization: Single-Center Study.

  2020cites this paper
• Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions.

  2020cites this paper
• Over 20-Year Follow-up of Patients with Hepatic Glycogen Storage Diseases: Single-Center Experience

  2020cites this paper
• Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review

  2020cites this paper
• Diagnosis of hepatic glycogen storage disease patients with overlapping clinical symptoms by massively parallel sequencing: a systematic review of literature

  2020cites this paper
• Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I

  2020cites this paper
• Glicogenose Tipo I (Doença de Von Gierke): Relato de Dois Casos com Grave Dislipidemia

  2020cites this paper
• Hypertriglycéridémie majeure révélant une glycogénose type I: A propos d’un cas [ Major hypertriglyceridemia revealing glycogen storage disease type I: A case report ]

  2020cites this paper
• Hereditäre Lebererkrankungen

  2020cites this paper
• Inherited metabolic disorders and dyslipidaemia

  2019cites this paper
• Development of Hepatocellular Carcinoma in Patients with Glycogen Storage Disease: a Single Center Retrospective Study

  2019cites this paper
• The 3’-UTR SNP rs2229611 in G6PC1 affects mRNA stability, expression and GSD-Ia risk

  2019cites this paper
• Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry.

  2019cites this paper
• Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.

  2019cites this paper
• Hepatic stress associated with pathologies characterized by disturbed glucose production

  2019influential citation
• Lactate and cancer: a "lactatic" perspective on spinal tumor metabolism (part 1).

  2019cites this paper
• Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III

  2019cites this paper
• Causes of AA amyloidosis: a systematic review

  2019cites this paper
• Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach

  2019cites this paper
• Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor‐developing stage

  2019cites this paper
• Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases

  2018cites this paper
• Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia

  2018cites this paper
• Pathological Classification and Surgical Approach to Hepatocellular Adenomas

  2018cites this paper
• A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring

  2018cites this paper
• Inborn Errors of Metabolism with Hypoglycemia Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis

  2018cites this paper
• G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a

  2018cites this paper
• Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis.

  2018cites this paper
• Metabolic adaptations in models of fatty liver disease: Of mice and math

  2017influential citation
• Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control

  2017cites this paper
• 3'-UTR SNP rs2229611 in G6PC1 affects mRNA stability, expression and Glycogen Storage Disease type-Ia risk.

  2017cites this paper
• HBPD Table of Contents, Vol. 16, No. 6, 2017

  2017cites this paper
• Metabolic adaptations in models of fatty liver disease Hijmans

  2017influential citation
• Pathobiology of the Hepatic Glycogen Storage Diseases

  2017cites this paper
• Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia

  2017cites this paper
• Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control

  2017influential citation
• Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy

  2017cites this paper
• Hepatic function of FcRn revealed: Implications for overcoming drug‐mediated hepatotoxicity

  2017cites this paper
• JIMD Reports, Volume 26

  2016cites this paper
• Hepatocellular Adenoma: ICD-O code: 8170/0

  2016cites this paper
• Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy

  2016cites this paper
• Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation

  2016cites this paper
• Etiološki pristup hipoglikemiji u djece

  2016cites this paper
• Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease

  2015cites this paper
• Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I.

  2015cites this paper
• Hepatic glycogen storage disorders: what have we learned in recent years?

  2015cites this paper
• Hepatocellular Adenomas and Carcinoma in Asymptomatic, Non-Cirrhotic Type III Glycogen Storage Disease.

  2015cites this paper
• Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I.

  2015cites this paper
• Giant hepatocellular adenoma in a previously obese thirteen-year-old boy.

  2015cites this paper
• GLYCOGENOSES Lipids in hepatic glycogen storage diseases : pathophysiology , monitoring of dietary management and future directions

  2015cites this paper
• Glucose-6-phosphatase (G6PC1) promoter polymorphism associated with glycogen storage disease type 1a among the Indian population

  2015cites this paper
• Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions

  2015cites this paper
• [History case of multiple hepatic adenomas in adolescent with severe course of glycogen storage disease type lb].

  2014cites this paper
• Pregnancy in Women With Glycogen Storage Disease Ia and Ib

  2014cites this paper
• Resection, transplantation and local regional therapies for liver adenomas

  2014cites this paper
• Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

  2014cites this paper
• СЛУЧАЙ МНОЖЕСТВЕННЫХ АДЕНОМ ПЕЧЕНИ У ПОДРОСТКА С ТЯЖЕЛЫМ ТЕЧЕНИЕМ ГЛИКОГЕНОВОЙ БОЛЕЗНИ ТИПА IB

  2014cites this paper
• Successful treatment of multiple hepatocellular adenomas with percutaneous radiofrequency ablation.

  2013cites this paper
• Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.

  2013cites this paper
• Multiple Hepatic Adenomas in a Child with Microvillus Inclusion Disease

  2013cites this paper
• Aggressive therapy improves cirrhosis in glycogen storage disease type IX.

  2013cites this paper
• Benign Hepatocellular Tumors in Children: Focal Nodular Hyperplasia and Hepatocellular Adenoma

  2013cites this paper
• Menorrhagia in Patients With Type I Glycogen Storage Disease

  2013cites this paper
• Glycogen Storage Disease type 1a – a secondary cause for hyperlipidemia: report of five cases

  2013cites this paper